This grant supports research on how BNIP3-mediated mitophagy affects beta cell identity and immune response in type 1 diabetes, aiming to uncover new therapeutic approaches.
Funder: Diabetes Research Connection
Due Dates: Rolling
Funding Amounts: Up to $75,000 per research project; typically supports one-year projects.
Summary: Supports research on BNIP3-mediated mitophagy in beta cells to uncover new therapeutic strategies for type 1 diabetes.
Key Information: Focused on early-career scientists and novel, peer-reviewed T1D research.
This grant opportunity, supported by the Diabetes Research Connection, funds innovative research investigating how BNIP3-mediated mitophagy regulates pancreatic beta cell identity and immunogenicity in type 1 diabetes (T1D). The project, led by Dr. Geming Lu, explores the role of BNIP3 in mitochondrial autophagy and its impact on inflammation and immune targeting of beta cells in T1D. The goal is to identify new therapeutic and preventative strategies for T1D by understanding how deficiencies in BNIP3 may contribute to disease progression. This area of mitochondrial autophagy is largely unexplored in T1D, making the research highly novel and potentially transformative.